文献速递肾癌与肾肿瘤

肾门肿瘤肾手术的功能与肿瘤学结局:为风险适应管理决策提供依据

Functional and Oncological Outcomes of Renal Surgery for Hilar Tumors: Informing the Decisions in Risk-Adapted Management.
PubMed 文献 · Urology · 2021-07-29

该回顾性研究纳入2008至2018年间1951例小于5cm的孤立性肾肿瘤患者,比较肾门与非肾门肿瘤行肾部分切除术(PN)或根治性肾切除术(RN)的安全性和疗效。肾门肿瘤行PN较RN肾功能和总生存更好,≥II级并发症风险无统计学显著升高。肾门位置不应视为PN的禁忌证。

要点

  • 肾门肿瘤行PN的肿瘤学结局与非肾门肿瘤相当。
  • 肾门肿瘤行PN的≥II级并发症发生率高于非肾门肿瘤(13% vs 8.6%)。
  • 肾门肿瘤行PN较RN肾功能和总生存更优,并发症风险无统计学显著升高。

核心结论

  • 肾门肿瘤行PN的肿瘤学结局与非肾门肿瘤相当,但并发症风险更高。
  • 肾门肿瘤行PN较RN肾功能和总生存更优,≥II级并发症风险无统计学显著升高。
  • 肾门位置不应视为PN的禁忌证。

研究设计与样本

  • 回顾性队列研究,纳入2008至2018年间1951例小于5cm的孤立性肾肿瘤患者。
  • 肾门肿瘤定义为内侧位置、毗邻肾血管的肿瘤。
  • 399例肾门肿瘤(292例计划行PN,107例计划行RN),1552例非肾门肿瘤(计划行PN)。
  • 采用Kaplan-Meier法估计无复发生存、癌症特异性生存和总生存。

主要发现

  • 肾门与非肾门肿瘤行PN的患者生存指标无显著差异。

临床怎么用

  • 对于小于5cm的肾门肿瘤,PN可作为可选术式,但需告知并发症风险较高。
  • 肾门肿瘤行PN可能获得更好的肾功能和总生存,决策时应综合评估。

局限性

  • 回顾性研究设计,存在选择偏倚可能。
  • 样本来自单中心机构记录。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the safety and efficacy of partial nephrectomy (PN) in comparison to radical nephrectomy (RN) for surgically managed renal hilar tumors. MATERIALS AND METHODS: We retrospectively reviewed institutional records of patients with a small (<5 cm) solitary renal (hilar or non-hilar) mass who underwent PN or RN between 2008 and 2018. Hilar tumors were defined as those at medial position, abutting the renal vessels. Recurrence-free, cancer-specific, and overall survival were estimated using the Kaplan-Meier method. RESULTS: Of 1,951 eligible patients, 399 had hilar tumors (292 scheduled for PN, 107 RN) and 1,552 had non-hilar tumors (scheduled for PN). We found no significant differences in survival measures between hilar and non-hilar tumors in patients selected for PN. Patients scheduled for PN for hilar tumors had higher rates of ≥grade II postoperative surgical complications compared to patients scheduled to receive PN for non-hilar tumors (13% vs 8.6%; log-rank P = .018) and non-statistically significantly elevated rates of ≥grade II complications compared to patients scheduled for RN for hilar tumors (13% vs 6.5%; difference 6%, 95% CI 0.4%, 13%; log-rank P = .07). CONCLUSION: PN for hilar and non-hilar renal masses (<5cm) experience comparable oncologic outcomes though increased risk of complications for hilar masses. PN for hilar tumors was associated with better renal function and overall survival with non-statistically elevated risk of grade II or higher complications than RN. A renal tumor located at the hilum should not be a contra-indication for performing PN.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Alvim RG, Tin AL, Nogueira L, et al. Functional and Oncological Outcomes of Renal Surgery for Hilar Tumors: Informing the Decisions in Risk-Adapted Management. Urology. 2021. PMID: 34331997. doi:10.1016/j.urology.2021.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。